Literature DB >> 17331655

Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice.

F Xu1, A M Grande, J K Robinson, M L Previti, M Vasek, J Davis, W E Van Nostrand.   

Abstract

Cerebral microvascular amyloid beta protein (Abeta) deposition and associated neuroinflammation are increasingly recognized as an important component leading to cognitive impairment in Alzheimer's disease and related cerebral amyloid angiopathy (CAA) disorders. Transgenic mice expressing the vasculotropic Dutch/Iowa (E693Q/D694N) mutant human Abeta precursor protein in brain (Tg-SwDI) accumulate abundant cerebral microvascular fibrillar amyloid deposits exhibiting robust neuroinflammation. In the present study, we sought to determine if the unique amyloid pathology of Tg-SwDI mice was associated with deficits in behavioral performance. Behavioral performance tests that assessed a variety of psychological functions, including overall activity, motor ability, balance and strength, anxiety, impulsivity, and learning were conducted on homozygous Tg-SwDI mice and similarly aged wild-type C57Bl/6 mice. Our results indicate that Tg-SwDI mice were impaired in the performance of the Barnes maze learning and memory task at 3, 9, and 12 months of age. While more widespread cerebral microvascular Abeta pathology was evident in older animals, the evaluation of the Abeta pathology in the 3 months old transgenic animals revealed specific accumulation of microvascular amyloid and markedly elevated numbers of reactive astrocytes and activated microglia restricted to the subiculum. These findings indicate that early-onset accumulation of subicular microvascular amyloid and accompanying neuroinflammation correlates with impaired performance in the learning and memory task in Tg-SwDI mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331655      PMCID: PMC1949338          DOI: 10.1016/j.neuroscience.2007.01.043

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia?

Authors:  H V Vinters
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

Review 2.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  Clinical manifestations of cerebral amyloid angiopathy-related inflammation.

Authors:  Jessica A Eng; Matthew P Frosch; Kyungchan Choi; G William Rebeck; Steven M Greenberg
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

4.  Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin.

Authors:  T M Jay; M P Witter
Journal:  J Comp Neurol       Date:  1991-11-22       Impact factor: 3.215

5.  Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.

Authors:  T J Grabowski; H S Cho; J P Vonsattel; G W Rebeck; S M Greenberg
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

6.  Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.

Authors:  Johannes Attems; Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-12-04       Impact factor: 17.088

7.  Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.

Authors:  Ronald B DeMattos; Mark A O'dell; Maia Parsadanian; Jennie W Taylor; Judith A K Harmony; Kelly R Bales; Steven M Paul; Bruce J Aronow; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

8.  Glial reactions and the clearance of amyloid beta protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type.

Authors:  Marion L C Maat-Schieman; Haruyasu Yamaguchi; Ingrid M Hegeman-Kleinn; Corrie Welling-Graafland; Remco Natté; Raymund A C Roos; Sjoerd G van Duinen
Journal:  Acta Neuropathol       Date:  2004-03-10       Impact factor: 17.088

9.  Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy.

Authors:  K A C Harkness; A Coles; U Pohl; J H Xuereb; J C Baron; G G Lennox
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

10.  Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.

Authors:  Dietmar Rudolf Thal; Estifanos Ghebremedhin; Mario Orantes; Otmar D Wiestler
Journal:  J Neuropathol Exp Neurol       Date:  2003-12       Impact factor: 3.685

View more
  35 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis.

Authors:  Karienn S Montgomery; George Edwards; Yona Levites; Ashok Kumar; Catherine E Myers; Mark A Gluck; Barry Setlow; Jennifer L Bizon
Journal:  Hippocampus       Date:  2015-10-19       Impact factor: 3.899

3.  Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice.

Authors:  Susan A Austin; Colin K Combs
Journal:  Neurobiol Aging       Date:  2008-12-05       Impact factor: 4.673

Review 4.  Murine models of Alzheimer's disease and their use in developing immunotherapies.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Biochim Biophys Acta       Date:  2010-05-13

5.  Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology.

Authors:  Shan Liu; Ariel Breitbart; Yanjie Sun; Pankaj D Mehta; Allal Boutajangout; Henrieta Scholtzova; Thomas Wisniewski
Journal:  J Neurochem       Date:  2013-11-06       Impact factor: 5.372

6.  Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy.

Authors:  Laibaik Park; Kenzo Koizumi; Sleiman El Jamal; Ping Zhou; Mary Lou Previti; William E Van Nostrand; George Carlson; Costantino Iadecola
Journal:  Stroke       Date:  2014-04-29       Impact factor: 7.914

7.  Quantitative measurement of postural sway in mouse models of human neurodegenerative disease.

Authors:  D Hutchinson; V Ho; M Dodd; H N Dawson; A C Zumwalt; D Schmitt; C A Colton
Journal:  Neuroscience       Date:  2007-07-21       Impact factor: 3.590

8.  Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease.

Authors:  Jodi R Paul; Hira A Munir; Thomas van Groen; Karen L Gamble
Journal:  Neurobiol Dis       Date:  2018-03-11       Impact factor: 5.996

Review 9.  Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Authors:  Thomas Wisniewski; Allal Boutajangout
Journal:  Brain Struct Funct       Date:  2009-12-10       Impact factor: 3.270

10.  In vivo hippocampal measurement and memory: a comparison of manual tracing and automated segmentation in a large community-based sample.

Authors:  Nicolas Cherbuin; Kaarin J Anstey; Chantal Réglade-Meslin; Perminder S Sachdev
Journal:  PLoS One       Date:  2009-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.